Main

Fields of interest:

• Leukemia
• Lymphoma
• Coagulation

Recent publications:

Y. Li, N. Clough, C.J. Hogan, B.L. Abbott and Z. Dai:
BCR-ABL induces abnormal cytoskeleton remodeling, B1 integrin clustering, and increased cell adhesion to fibronectin through ABL interactor 1 pathway,
J. Cell Sci., Vol. 120, (2007), pp. 1436-46.

B.L. Abbott:
Cytoprotectants in cancer therapy,
Clinical Advances in Hematology and Oncology, March, 2007. (in press).

B.L. Abbott American College Physicians, Physicians Information and Education Resource (PIER) Section editor:
Chronic Lymphocytic Leukemia,
http://www.ACPOnline.com, 2005-2007.

B.L. Abbott:
Lymphoma and Myeloma: a 2006 American Society of Clinical Oncology meeting update,
Clinical Lymphoma and Myeloma, Vol. 7, (2006), pp. 30-32.

B.L. Abbott:
Chronic Lymphocytic Leukemia: Recent Advances in Diagnosis and Treatment,
CME Activity, The Oncologist, January 2006.

R. Chen, B.L. Abbott and H. Myint:
Treatment of HIV associated Burkitt’s lymphoma in the presence of severe hepatic dysfunction: a case report and literature review,
Clinical Advances in Hematology & Oncology, Vol. 4,, (2006), pp. 844-847.

B.L. Abbott:
ABCG2 / BCRP: a stem cell cytoprotectant,
Clinical Advances in Hematology and Oncology, Vol. 4(1), (2006), p. 63.

B.L. Abbott (co-editor) and M. Patton:
140 Things you need to know about your autologous bone marrow or stem cell transplant,
MGC Publications, 2005.

T.R. Pacheco and B.L. Abbott:
Leukemic and lymphomatous infiltrates of the skin,
Dermatology Secrets, 3rd edition, 2005.

B.L. Abbott:
Inside Blood: Does “Mini-transplantation” have “mini toxicity?
Blood, September 1, 2004.